Both in Surgical Instruments
Neuropace vs Avita Medical
Over the past year NPCE returned +32.6% and RCEL returned +324.9%; their daily moves had a correlation of 0.15.
NPCE +32.6% RCEL +324.9%Growth of $1, one year, split-adjusted
| Metric | NPCE | RCEL |
|---|---|---|
| Price | $12.46 | $16.06 |
| Market cap | $427.7M | $496.7M |
| Today | +0.97% | +4.22% |
| 1 month | −5.7% | +21.2% |
| 6 months | −26.9% | +278.8% |
| Year to date | −19.3% | +365.5% |
| 1 year | +25.4% | +315.0% |
| Revenue growth (YoY) | +17.1% | +17.8% |
| Gross margin | 82.8% | 81.9% |
| Net margin | −27.2% | −35.3% |
| P/E (TTM) | — | — |
| Price / sales | 4.3× | 6.6× |
| Net cash | -$7.3M | -$35.5M |
| Dividend yield | — | — |
| Volatility (60d) | 40.2% | 69.7% |
| Short % of float | 3.7% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).